Frazier Life Sciences Management as of Dec. 31, 2022
Portfolio Holdings for Frazier Life Sciences Management
Frazier Life Sciences Management holds 44 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Hillevax (HLVX) | 10.2 | $163M | 9.8M | 16.73 | |
| Imago Biosciences | 8.9 | $143M | 4.0M | 35.95 | |
| Arcutis Biotherapeutics (ARQT) | 8.0 | $129M | 8.7M | 14.80 | |
| Chinook Therapeutics | 7.1 | $114M | 4.3M | 26.20 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 6.3 | $102M | 9.3M | 10.90 | |
| Syndax Pharmaceuticals (SNDX) | 5.9 | $94M | 3.7M | 25.45 | |
| Phathom Pharmaceuticals (PHAT) | 5.9 | $94M | 8.4M | 11.22 | |
| Krystal Biotech (KRYS) | 4.9 | $79M | 1000k | 79.22 | |
| Mirum Pharmaceuticals (MIRM) | 4.7 | $75M | 3.9M | 19.50 | |
| Verona Pharma Sponsored Ads (VRNA) | 4.6 | $74M | 2.8M | 26.13 | |
| Vaxcyte (PCVX) | 4.2 | $67M | 1.4M | 47.95 | |
| Rhythm Pharmaceuticals (RYTM) | 3.4 | $55M | 1.9M | 29.12 | |
| Allakos (ALLK) | 2.5 | $40M | 4.8M | 8.42 | |
| Anaptysbio Inc Common (ANAB) | 1.7 | $28M | 900k | 30.99 | |
| Tarsus Pharmaceuticals (TARS) | 1.6 | $26M | 1.8M | 14.66 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.6 | $26M | 1.4M | 18.30 | |
| Replimune Group (REPL) | 1.6 | $25M | 932k | 27.20 | |
| Cogent Biosciences (COGT) | 1.5 | $24M | 2.1M | 11.56 | |
| Alpine Immune Sciences | 1.4 | $22M | 3.0M | 7.35 | |
| Kalvista Pharmaceuticals (KALV) | 1.4 | $22M | 3.2M | 6.76 | |
| Gritstone Oncology Ord (GRTSQ) | 1.1 | $18M | 5.2M | 3.45 | |
| Sutro Biopharma (STRO) | 0.9 | $14M | 1.8M | 8.08 | |
| ACADIA Pharmaceuticals (ACAD) | 0.8 | $14M | 857k | 15.92 | |
| Silence Therapeutics Ads (SLN) | 0.8 | $13M | 881k | 15.25 | |
| Trevi Therapeutics (TRVI) | 0.8 | $13M | 6.7M | 1.93 | |
| Cerevel Therapeutics Hldng I (CERE) | 0.8 | $12M | 393k | 31.54 | |
| Merus N V (MRUS) | 0.7 | $12M | 747k | 15.47 | |
| Vectivbio Hldg Ord Shs | 0.7 | $12M | 1.3M | 8.61 | |
| Avidity Biosciences Ord (RNA) | 0.7 | $11M | 500k | 22.19 | |
| Immunovant (IMVT) | 0.6 | $10M | 586k | 17.75 | |
| Tyra Biosciences (TYRA) | 0.6 | $10M | 1.3M | 7.60 | |
| Bluebird Bio (BLUE) | 0.6 | $10M | 1.4M | 6.92 | |
| Arvinas Ord (ARVN) | 0.6 | $9.8M | 285k | 34.21 | |
| Prothena Corp SHS (PRTA) | 0.5 | $7.7M | 128k | 60.25 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.4 | $7.1M | 3.7M | 1.90 | |
| Intellia Therapeutics (NTLA) | 0.4 | $7.1M | 204k | 34.89 | |
| Theseus Pharmaceuticals | 0.4 | $7.0M | 1.4M | 4.98 | |
| Passage Bio (PASG) | 0.3 | $5.2M | 3.8M | 1.38 | |
| Zymeworks Del (ZYME) | 0.3 | $4.8M | 610k | 7.86 | |
| Aclaris Therapeutics (ACRS) | 0.3 | $4.6M | 290k | 15.75 | |
| Essa Pharma Com New (EPIX) | 0.1 | $1.5M | 605k | 2.52 | |
| Aptinyx | 0.0 | $537k | 1.9M | 0.29 | |
| Newamsterdam Pharma Company *w Exp 11/22/202 (NAMSW) | 0.0 | $434k | 500k | 0.87 | |
| Nabriva Therapeutics Shs New 2022 (NBRVF) | 0.0 | $32k | 17k | 1.89 |
